Unrecognized Renal Transplants as a Potential Source of False-Positive Interpretation of FDG PET

Clinical Nuclear Medicine

Volumn 28, Issue 8, 2003, Pages 655-657

  Guan, Liang ^a   Dadparvar, Simin ^a   Reich, Phillip ^a   Yu, Jian Qin ^a   Bhargava, Peeyush ^a   Alavi, Abass ^a   Zhuang, Hongming ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

FDG PET; Kidney; Transplants

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE RECONSTRUCTION; KIDNEY TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; KIDNEY; LABORATORY DIAGNOSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; PELVIS TUMOR; SCINTISCANNING; SINGLE BLIND PROCEDURE; URINE;

ADULT; AGED; DIAGNOSTIC ERRORS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PELVIC NEOPLASMS; RADIOPHARMACEUTICALS; SINGLE-BLIND METHOD; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1442284837     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200308000-00007     Document Type: Article

References (9)

1. Port FK. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions. Kidney Int. 1995;48:S3-S6.
2. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641-1674.
3. Hustinx R, Benard F, Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med. 2002;32:35-46.
4. Cook GJR, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med. 1999;26:1363-1378.
5. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47-59.
6. Bedigian MP, Benard F, Smith RJ, et al. Whole-body positron emission tomography for oncology imaging using single transmission scanning with segmentation and ordered subsets expectation maximization (OSEM) reconstruction. Eur J Nucl Med. 1998;25:659-661.
7. Bhargava P, Zhuang H, Hickeson M, et al. Pelvic kidney mimicking recurrent colon cancer on FDG positron emission tomographic imaging. Clin Nucl Med. 2002;27:602-603.
8. Zhuang H, Yeh DMY, Mozley PD, et al. Horseshoe kidney on FDG positron emission tomographic imaging is easily confused with malignancy. Clin Nucl Med. 2001;26:351-352.
9. Zhuang H, Duarte PS, Pourdehnad M, et al. Standardized uptake value as an unreliable index of renal disease on FDG-PET imaging. Clin Nucl Med. 2000;25:358-360.